科室与专家门诊
妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。
行此手术的医生
编辑搜索过滤条件
close
缩小搜索范围
-
未找到姓氏以该字母开头的医生 A
A
-
未找到姓氏以该字母开头的医生 B
B
-
未找到姓氏以该字母开头的医生 C
C
-
主动 查找姓氏以该字母开头的医生 D
D
-
未找到姓氏以该字母开头的医生 E
E
-
未找到姓氏以该字母开头的医生 F
F
-
未找到姓氏以该字母开头的医生 G
G
-
未找到姓氏以该字母开头的医生 H
H
-
未找到姓氏以该字母开头的医生 I
I
-
未找到姓氏以该字母开头的医生 J
J
-
未找到姓氏以该字母开头的医生 K
K
-
未找到姓氏以该字母开头的医生 L
L
-
未找到姓氏以该字母开头的医生 M
M
-
未找到姓氏以该字母开头的医生 N
N
-
未找到姓氏以该字母开头的医生 O
O
-
未找到姓氏以该字母开头的医生 P
P
-
未找到姓氏以该字母开头的医生 Q
Q
-
未找到姓氏以该字母开头的医生 R
R
-
查找姓氏以该字母开头的医生 S
S
-
未找到姓氏以该字母开头的医生 T
T
-
未找到姓氏以该字母开头的医生 U
U
-
未找到姓氏以该字母开头的医生 V
V
-
未找到姓氏以该字母开头的医生 W
W
-
未找到姓氏以该字母开头的医生 X
X
-
未找到姓氏以该字母开头的医生 Y
Y
-
未找到姓氏以该字母开头的医生 Z
Z
重置所有过滤器
搜索提示
- 给搜索词加引号。
- 即使搜索栏没有显示自动建议,也请点击“搜索”,您或许仍然可以获得结果。
显示$起始范围 - $结束范围/源自可用$可用医生
-
- Internist
- Medical Geneticist
- Rochester, MN
擅长领域:
Gene therapy, Skeletal dysplasia, Osteogenesis imperfecta
July 13, 2024
- MedLine Plus. Genes and gene therapy. https://medlineplus.gov/genesandgenetherapy.html. Accessed Jan. 31, 2024.
- How gene therapy can cure or treat diseases. U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/how-gene-therapy-can-cure-or-treat-diseases. Accessed Feb. 8, 2024.
- Gene therapy basics. American Society of Gene + Cell Therapy. https://patienteducation.asgct.org/gene-therapy-101/gene-therapy-basics. Accessed Jan. 31, 2024.
- What are genetic therapies? National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/genetic-therapies. Accessed Jan. 31, 2024.
- What is gene therapy? U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/what-gene-therapy. Accessed Jan. 31, 2024.
- Flomenbergm P, et al. Overview of gene therapy, gene editing, and gene silencing. https://www.uptodate.com/contents/search. Accessed Jan. 31, 2024.
- Dara J, et al. Overview of gene therapy for inborn errors of immunity. https://www.uptodate.com/contents/search. Accessed Jan. 31, 2024.
- Kymriah (prescribing information). Novartis Pharmaceutical Corp.; 2022. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/kymriah-tisagenlecleucel. Accessed Jan. 31, 2024.
- Yescarta (prescribing information). Kite Pharma Inc.; 2023. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/yescarta-axicabtagene-ciloleucel. Accessed Jan. 31, 2024.
- Luxturna (prescribing information). Spark Therapeutics Inc.; 2022. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/luxturna. Accessed Jan. 31, 2024.
- Zolgensma (prescribing information). Novartis Gene Therapies Inc.; 2019. https://www.fda.gov/vaccines-blood-biologics/zolgensma. Accessed Jan. 31, 2024.
- Imlygic (prescribing information). Amgen Inc.; 2023. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/imlygic. Accessed Jan. 24, 2024.
- Shukla V, et al. The landscape of cellular and gene therapy products: Authorization, discontinuations and cost. Human Gene Therapy. Clinical Development. 2019; doi:10.1089/humc.2018.201.
- MedLine Plus. How does gene therapy work? https://medlineplus.gov/genesandgenetherapy.html. Accessed Jan. 31, 2024.
- Gene therapy — Frequently asked questions. National Organization for Rare Disorders Inc. https://rarediseases.org/gene-therapy/faqs. Accessed Jan. 31, 2024.
- Gene therapy — Frequently asked questions. Immune Deficiency Foundation. https://primaryimmune.org/understanding-primary-immunodeficiency/treatment/gene-therapy. Accessed Jan. 31, 2024.
- Medical review (expert opinion). Mayo Clinic. Feb. 8, 2024.
- Approved cellular and gene therapy products. U.S. Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products. Accessed Feb. 12, 2024.